BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wieder HA, Lassmann M, Allen-Auerbach MS, Czernin J, Herrmann K. Clinical use of bone-targeting radiopharmaceuticals with focus on alpha-emitters. World J Radiol 2014; 6(7): 480-485 [PMID: 25071888 DOI: 10.4329/wjr.v6.i7.480]
URL: https://www.wjgnet.com/1949-8470/full/v6/i7/480.htm
Number Citing Articles
1
Organische Chemie 2014Nachrichten aus der Chemie 2015; 63(3): 266 doi: 10.1002/nadc.201590092
2
M. Basely, D. Métivier, O. Aupée, S. Le Moulec, C. Hélissey, F.-R. Ferrand, A. Frison-Roche, M. Tazdaït, E. Gontier. Radiothérapie interne par dichlorure de radium223 : résultats préliminairesMédecine Nucléaire 2015; 39(5): 471 doi: 10.1016/j.mednuc.2015.08.003
3
Paul E. Wallner, Don C. Yoo, Jeremie Calais, Freddy E. Escorcia, Carina Mari Aparici, Jeff Michalski, Michael Morris, Zachary S. Morris, Daniel Pryma, Bryan M. Rabatic, Navesh Sharma, Neha Vapiwala, Munir V. Ghesani, Rathan M. Subramaniam, William Small, Naomi R. Schechter. ACR–ACNM–ARS–ASTRO–SNMMI Practice Parameter for the Performance of Therapy With RadiopharmaceuticalsAmerican Journal of Clinical Oncology 2024; 47(4): 169 doi: 10.1097/COC.0000000000001072
4
Hümeyra BATTAL, Suna ERDOĞAN. The Role of Radiopharmaceuticals in the Bone Metastases TherapyFabad Journal of Pharmaceutical Sciences 2023;  doi: 10.55262/fabadeczacilik.1191048
5
Arlindo R. Ferreira, André Abrunhosa-Branquinho, Marília Jorge, Luís Costa, Inês Vaz-Luís. International Manual of Oncology Practice2015; : 867 doi: 10.1007/978-3-319-21683-6_40
6
Patricia E. Edem, Jesper Fonslet, Andreas Kjær, Matthias Herth, Gregory Severin. In Vivo Radionuclide Generators for Diagnostics and TherapyBioinorganic Chemistry and Applications 2016; 2016: 1 doi: 10.1155/2016/6148357
7
Vincenzo Serretta, Maria Rosaria Valerio, Renato Costa, Vincenzo Tripoli, Alessandra Murabito, Alessandro Princiotta, Cristina Scalici Gesolfo, Nicolò Borsellino, Francesco Verderame, Vittorio Gebbia, Maria Licari, Chiara Sanfilippo. Radium-223 treatment in castration resistant bone metastatic prostate cancer. Should be the primary tumor always treated?Urologic Oncology: Seminars and Original Investigations 2019; 37(12): 964 doi: 10.1016/j.urolonc.2019.08.009
8
Benedetta Pagano, Sergio Baldari. Clinical Applications of Nuclear Medicine Targeted Therapy2018; : 345 doi: 10.1007/978-3-319-63067-0_26
9
Vinod Patel, Megan Burns, Sheelen Patel, Sanford Grossman, Rana Wali, Isabel Sassoon, Elias Pintus, Marianne Henien. The presenting dental status of solid tumours with bone metastases requiring bone-targeting agents - part 3: prostate cancerBritish Dental Journal 2022;  doi: 10.1038/s41415-022-3928-0
10
E. Johanna L. Stéen, Patricia E. Edem, Kamilla Nørregaard, Jesper T. Jørgensen, Vladimir Shalgunov, Andreas Kjaer, Matthias M. Herth. Pretargeting in nuclear imaging and radionuclide therapy: Improving efficacy of theranostics and nanomedicinesBiomaterials 2018; 179: 209 doi: 10.1016/j.biomaterials.2018.06.021
11
Diagnostic Imaging: Nuclear Medicine2016; : 482 doi: 10.1016/B978-0-323-37753-9.50125-0
12
Rebecca King, Nikki Tanna, Vinod Patel. Medication-related osteonecrosis of the jaw unrelated to bisphosphonates and denosumab—a reviewOral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2019; 127(4): 289 doi: 10.1016/j.oooo.2018.11.012
13
Helena Luna Pais, Irina Alho, Inês Vendrell, André Mansinho, Luís Costa. Radionuclides in oncology clinical practice – review of the literatureDalton Transactions 2017; 46(42): 14475 doi: 10.1039/C7DT01929G
14
Luigia Florimonte, Luca Dellavedova, Lorenzo Stefano Maffioli. Radium-223 dichloride in clinical practice: a reviewEuropean Journal of Nuclear Medicine and Molecular Imaging 2016; 43(10): 1896 doi: 10.1007/s00259-016-3386-5
15
Roger von Moos, Luis Costa, Carla Ida Ripamonti, Daniela Niepel, Daniele Santini. Improving quality of life in patients with advanced cancer: Targeting metastatic bone painEuropean Journal of Cancer 2017; 71: 80 doi: 10.1016/j.ejca.2016.10.021